An artificial intelligence firm working to create novel ultrasound technology, which it claims is vastly more sensitive that traditional equipment, just raised $25 million.
Healthcare investment firm Deerfield Management Co. led the Series A financing round, with additional contributions from Wing Venture Capital, Alter Venture Partners and Time BioVentures.
DeepSight said traditional ultrasound is limited in its sensitivity, depth penetration and clarity. The San Francisco-based startup hopes to fix this using patented hardware, software and AI algorithms.
“Based on internal studies, our technology has the potential to achieve 100 times greater sensitivity, ultimately allowing us to deliver better patient care,” founder and CEO Nader Sadrzadeh said Monday, Oct. 11.
DeepSight was first launched in 2019 and has amassed more than 20 patents, according to its website. The firm said it hopes to broaden the list of diagnostic uses for ultrasound, supplanting “more costly and less accessible” imaging modalities such as CT or MRI.
Marty Stempniak has covered healthcare since 2012, with his byline appearing in the American Hospital Association's member magazine, Modern Healthcare and McKnight's. Prior to that, he wrote about village government and local business for his hometown newspaper in Oak Park, Illinois. He won a Peter Lisagor and Gold EXCEL awards in 2017 for his coverage of the opioid epidemic.